yt.exm spent the last 12 months under 2c.if it doesnt make another leg up from here very soon those buyers sub 2c will get impatient and theres alot of them.i could be wrong.its just my opinion.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
